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Objective: The aims of this study were to examine: (i) base-
line pressure pain thresholds in patients with chronic fatigue 
syndrome and those with chronic low back pain compared 
with healthy subjects; (ii) the change in mean pain threshold 
in response to exercise; and (iii) associations with exercise-
induced increase in nitric oxide. 
Participants: Twenty-six patients with chronic fatigue syn-
drome suffering of chronic pain, 21 patients with chronic 
low back pain and 31 healthy subjects.
Methods: Participants underwent a submaximal aerobic 
exercise protocol on a bicycle ergometer, preceded and fol-
lowed by venous blood sampling (nitric oxide) and algom-
etry (hand, arm, calf, low back). 
Results: Patients with chronic fatigue syndrome presented 
overall lower pain thresholds compared with healthy sub-
jects and patients with chronic low back pain (p < 0.05). No 
significant differences were found between healthy subjects 
and patients with chronic low back pain. After submaximal 
aerobic exercise, mean pain thresholds decreased in patients 
with chronic fatigue syndrome, and increased in the others 
(p < 0.01). At baseline, nitric oxide levels were significantly 
higher in the chronic low back pain group. After controlling 
for body mass index, no significant differences were seen be-
tween the groups at baseline or in response to exercise. Nitric 
oxide was not related to pain thresholds in either group. 
Conclusion: The results suggest hyperalgesia and abnormal 
central pain processing during submaximal aerobic exercise 
in chronic fatigue syndrome, but not in chronic low back pain. 
Nitric oxide appeared to be unrelated to pain processing.
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INTRODUCTION 
While there is a body of literature on chronic pain, few studies 
have made direct comparisons between different chronic pain 
conditions. Comparing pain disorders is crucial for unravel-
ling the differences and similarities in the nature of chronic 
pain. Chronic low back pain (CLBP) is a well-known example 
of chronic pain. We are less familiar with chronic pain ex-
perienced by patients with chronic fatigue syndrome (CFS). 
Although the majority of patients with CFS experience chronic 
widespread musculoskeletal pain, evidence on the nature of 
this pain is lacking (1). 
Central sensitization has been documented as an important 
mechanism in several chronic pain populations, including 
fibromyalgia, whiplash-associated disorder, and osteoarthritis 
(2, 3). In patients with CLBP, augmented pain sensitivity and 
cortical reorganization have been described, suggesting abnor-
mal central pain processing (4, 5). Generalized hyperalgesia at 
locations in the lower back (6, 7) and at sites unrelated to the 
lower back (7) have been reported. Central pain mechanisms 
may contribute to recurrent pain in patients with CLBP. 
In CFS the central sensitization hypothesis has been sug-
gested (8). Central mechanisms may be responsible for the 
deregulated anti-nociception. Whitheside et al. (9) reported 
a decrease in pressure pain threshold (PPT) in response to 
exercise in 5 patients with CFS. In healthy individuals PPTs 
increase following different types of exercise. Endogenous 
opioid release, however, with mixed support (10), or other 
spina/supraspinal nociceptive inhibitory mechanisms (11) have 
been reported to be involved in the increased pain thresholds 
following exercise. Increased nociceptive perception after 
exercise may be suggestive of a deregulated anti-nociceptive 
mechanism. 
The latter may partly explain the typical exacerbation 
of symptoms (including pain) following vigorous physical 
activity in patients with CFS (12), a primary characteristic 
that is evident in up to 95% of patients with CFS (13). This 
is not present in other disorders where fatigue is a predomi-
nant symptom, such as depression, rheumatoid arthritis, or 
multiple sclerosis (14). Post-exertional malaise is one of the 
best predictors of the differential diagnosis of CFS and major 
depressive disorder (15).
Nitric oxide (NO) plays a complex role in nociceptive 
processing (11). Although evidence exists regarding the ben-
eficial effects of the release of small amounts of NO during 
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inhibition of nociceptive pathways (16), excessive amounts 
of NO, could contribute to central sensitization in CFS (8). 
Excessive amounts of NO have been documented in patients 
with CFS (17). NO is able to reduce the nociceptive inhibi-
tory activity of the central nervous system, leading to central 
sensitization of dorsal horn neurones (18), which could explain 
chronic widespread pain in patients with CFS (8). 
A single bout of physical activity triggers release of NO 
(19) and could consequently further raise elevated NO levels 
in patients with CFS. The above-mentioned hypothesis on 
NO could account for the increase in pain following vigorous 
exercise in patients with CFS. Besides the evidence in sup-
port of abnormal central pain processing in CLBP, nociceptive 
physiology in relation to exercise/physical activity has not been 
studied in CLBP. Furthermore, no data addressing levels of NO 
and exercise are available for patients with CLBP. 
The goal of the present study was to examine the change in 
PPTs and serum NO levels in response to a submaximal aerobic 
bicycle exercise in patients with CFS with chronic widespread 
pain, pain-free healthy subjects, and patients with CLBP. Fur-
thermore, the association between NO and PPT changes were 
studied. It was hypothesized that: (i) baseline PPTs are lower 
in the patient groups compared with healthy subjects, (ii) PPTs 
decrease following submaximal aerobic exercise in patients 
with CFS, and (iii) impaired pain response to exercise is as-
sociated with an exercise-induced increase in NO levels.
MATERIALS AND METHODS 
Research design 
We compared the response to a submaximal exercise test on a bicy-
cle ergometer between patients with CFS with chronic widespread 
pain, patients with CLBP, and healthy sedentary subjects. First the 
participants received a leaflet explaining the purpose of the research. 
Participants were asked to read the information leaflet carefully and 
to sign the informed consent form to indicate agreement to participate 
in the study. The hypothesis of the study was not discussed with the 
patients prior to the completion of the tests. The protocol and the 
information leaflet were approved by the local ethics committee (Uni-
versity Hospital Vrije Universiteit Brussel; O.G. 016). Demographic 
data were recorded, including age, height and weight. 
All participants underwent algometry and venous blood sampling for 
NO quantification immediately before and after a submaximal aerobic 
exercise bicycle test. Changes in NO and mean PPT following the 
exercise protocol were compared between the 3 groups.
Participants
All participants were contacted by telephone to verify a number of 
study requirements and to ask whether they were interested in partici-
pating in the trial. To fulfil the general inclusion criteria, participants 
had to be aged between 18 and 65, and had to be able to perform an 
ergometer bicycle test. Participants were excluded in case of pregnancy 
or up until one year postnatally, or if they had severe neurological or 
cardiovascular problems. In order to minimize confounding of the 
PPTs and NO analyses, all participants were asked to cease the use 
of analgesics and anti-depressants 24 h prior to study participation, 
and to avoid any intake of alcohol, caffeine, and nicotine on the day 
of study participation. 
Chronic fatigue syndrome patients. Twenty-six patients with CFS were 
randomly selected (randomly defined file numbers) from the medical 
files available at our university-based chronic fatigue clinic. Patients 
had to be diagnosed with CFS following the Centre for Disease Control 
and Prevention (CDCP) diagnostic criteria (12) and report Chronic 
Widespread Pain (CWP) following the criteria of the American College 
of Rheumatology (20). All patients underwent an extensive medical 
evaluation by the same physician (specialized in internal medicine) 
prior to study participation. This evaluation consisted of a standard 
physical examination, medical history, exercise capacity test and rou-
tine laboratory tests. Any active medical condition that may explain 
the presence of chronic fatigue, prohibits the diagnosis of CFS. The 
laboratory tests included a complete blood cell count, determina-
tion of the erythrocyte sedimentation rate, serum electrolyte panel, 
measures of renal, hepatic and thyroid function, as well as rheumatic 
and viral screens. If the patient’s medical history did not exclude a 
psychiatric problem at the time of onset, then a structured psychiatric 
interview was performed. In a number of cases further neurological, 
gynaecological, endocrine, cardiac and/or gastrointestinal evaluations 
were performed. The medical records were also reviewed to determine 
whether patients had any organic or psychiatric disorder that could 
explain their symptoms. If any of the additional analyses revealed any 
active medical condition that could explain the presence of a patient’s 
symptoms, this subject was excluded from the sample. 
Chronic low back pain-patients. In order to compare patients with CFS 
with another chronic pain population, 21 patients with CLBP were 
recruited via pamphlets in the University Hospital Brussels and via 
physical therapists. We used the criteria for non-specific LBP consist-
ent with those used in Flynn et al.’s study (21). Patients with CLBP 
had to experience at least 3 months of non-specific and chronic LBP, 
had to be sedentary (defined as having a sedentary job and perform-
ing < 3 h moderate physical activity/week; moderate activity defined 
as activity demanding at least 3 times the level of energy spent pas-
sively (22)), and had to be aged between 18 and 65 years. Patients 
with specific underlying pathology as the cause of CLBP (e.g. tumour, 
known disc derangement, trauma, infection, diagnosed inflammatory 
joint disease, spinal stenosis, spondylolysis or spondylolisthesis) were 
excluded. In addition, patients with a history of spinal fracture, severe 
degenerative change, severe scoliosis, osteoporosis, obesity, radicular 
signs, malignancies, and metabolic or rheumatological diseases, were 
excluded. Patients with a history of spinal surgery were not included 
in the study. 
Healthy control subjects. A healthy sedentary (see above) control 
group of 31 subjects was recruited among researcher’s acquaintances 
and by distributing pamphlets in the University Hospital Brussels, 
the Vrije Universiteit Brussel and the Artesis University College of 
Antwerp. Besides the above common criteria they could not suffer 
any pain complaints or severe systemic or psychiatric problems. This 
corresponds to activities with Metabolic Equivalents (METs) scores of 
3 or more in the compendium of physical activities (23). These criteria 
were assessed using the demographic questionnaire.
Outcome measures
Nitric oxide assay. Venous blood was collected in heparinized vacuum 
tubes. NO concentrations in the serum were analysed with a NO Quan-
titation Kit (Active Motif Inc., Carlsbad, CA, USA). NO measurements 
were based on total serum nitrite and nitrate levels. Preparation and 
analysis of the samples was performed following the manufacturer’s 
protocol. Blood samples were coded and transferred to RED Labora-
tories (Zellik, Belgium), where the samples were analysed blindly. 
Algometry. PPTs were measured with an analogue Fisher algometer 
(Force Dial model FDK 40 Push Pull Force Gage, Wagner Instruments, 
Greenwich CT, USA) immediately before and after the exercise bout 
in the skin web between thumb and index finger (9) (referred to as 
hand PPT), 5 cm lateral to the spinous process of L3 (6) (referred to 
as back PPT), at the insertion of the deltoid muscle (referred to as arm 
PPT), and at the proximal third of the calf (referred to as calf PPT). 
These sites were chosen in order to test PPTs on non-specific locations 
both on the extremities and the trunk. The order of PPT testing was 
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randomized by lottery and always performed bilaterally. The force 
was gradually increased at a rate of 1 kg/s (24), by silently counting 
seconds while increasing pressure. PPT was defined as the point at 
which the pressure sensation changed to pain (2). The threshold was 
determined as the mean of the 2 last values out of 3 consecutive 
measurements, with a pause of 10 s between the measurements, a 
procedure found to be reliable in healthy subjects (24, 25). Pressure 
algometry has been found to be efficient and reliable in the exploration 
of physiopathological mechanisms involved in pain (26) and is useful 
for the evaluation of treatment outcome, as reviewed by Fischer (27). 
Whiteside et al. (9) previously used algometry in the skin between 
thumb and index to evaluate the difference in PPT before and after an 
exercise test in patients with CFS. Algometry was always conducted 
by the same researcher (MM).
Self-reported measurements. Self-report measures included a visual 
analogue scale (VAS) (28), ranging from 0 (no pain) to 100 (worst 
imaginable pain) mm to assess current pain intensity, and the Oswestry 
Disability Questionnaire (ODQ) (29) to evaluate disability in patients 
with CLBP. High levels of reliability and validity have been described 
for these questionnaires (28–30). The Short-Form Health Status Survey 
36 (SF-36) assesses functional status and well-being and quality of life 
(31). The SF-36 has been documented to have reliability and validity 
in a wide variety of patient populations (31) and it appears to be the 
most frequently used measure in CFS research (32). 
Exercise protocol
The complete exercise protocol (Fig. 1) consisted of a maximal of 6 
bouts of exercise on a bicycle ergometer, each bout followed by 90 s 
of rest. The exercise programme was incremental, starting at 20 Watt 
and augmenting in steps of 10 Watt/minute. Each exercise bout was 
introduced by a short warming-up period to overcome the inertia, 
starting from zero and gradually increasing by 1 Watt every 2 s. 
Thereafter, the actual exercise period consisted of 2 incremental 1-min 
steps. Finally, each bout finished off with a short cooling-down of 30 
s to prevent venous pooling. The participants were instructed to stop 
the test when they were getting tired and they felt that they could no 
longer reach a pedalling frequency of at least 70 revolutions per min. 
After the sixth exercise bout (ending at 130 Watt), the programme was 
completed. Depending on the individual capacity the complete test 
could be performed or prematurely discontinued. The rationale for this 
protocol was that everyone would be able to perform a submaximal 
exercise test by completing at least one or more exercise bouts. The 
rest periods between bouts were planned in order to permit relative 
recuperation, so that it would not be peripheral muscle pain or fatigue 
that caused premature ending of any bout. Intermittent exercise pro-
tocols are in line with exercise pathophysiology seen in patients with 
CFS. It has been demonstrated that a discontinuous graded exercise 
test did not greatly exacerbate the underlying disorder of patients with 
CFS (33). By interrupting the exercise, we aimed to postpone early 
acidosis, peripheral pain and fatigue and reduce the typical exacerba-
tion of symptoms. The purpose of providing 6 bouts was that even the 
healthy sedentary subjects would experience sufficient submaximal 
exercise stimulus. 
Statistical analysis 
All data were analysed using SPSS 12.0© for Windows (SPSS Inc. 
Headquarters, Wacker Drive, Chicago, IL, USA). Given the normality 
of the variables (one-sample Kolmogorov-Smirnov goodness-of-fit 
test), parametric statistics were used. 
Group characteristics. Mean and standard deviation (SD) for age, 
serum NO levels and the 8 bilateral PPT sites before and after exer-
cise were calculated. Comparability of the 3 groups for age, length, 
height, PPTs and NO was assessed with a one-way analysis of variance 
(ANOVA) and for gender with the χ2 test. Since obesity is related to 
endothelial dysfunction (34), results for NO were corrected for body 
mass index (BMI).
Changes in nitric oxide and mean pressure pain thresholds. The change 
in NO and PPT measurements were compared between the 3 groups 
prior to and following exercise with a 2-factor repeated measures 
ANOVA with group (CLBP, CFS and controls) and time (pre- and 
post-exercise) as factors. Age, gender, and exercise duration were 
entered as covariates. Since 26 participants were unable to complete 
all 6 bouts in the exercise protocol, exercise duration was entered as 
covariate in the repeated measures ANOVA. Bonferroni post hoc tests 
were used. The ANOVA results for NO were corrected for BMI as well 
as for age, gender, and exercise duration. Mean PPT was the average 
of the 8 PPTs measured on the right-hand and left-hand sides prior to 
and following exercise.
Correlations between nitric oxide and mean pressure pain thresholds. 
Pearson correlation coefficients were calculated to reveal possible cor-
relations between NO and mean PPTs. A power analysis determined 
that at least 21 participants per group were necessary to establish 
statistical significance at a power of 0.80. The significance level was 
set at 0.05. 
Fig. 1. Complete exercise protocol 
showing the 6 exercise bouts (shaded 
areas) and rest periods between bouts.
Warming up: Each exercise bout started 
with a warming-up period in which the 
workload was gradually increased by 1 
kWatt/2 s until the intended workload 
was reached. 
60”: Each plateau phase at a certain 
workload lasted for 60 s. Each exercise 
bout consisted of 2 plateau phases at 
incremental workloads.
Cooling down: Each exercise bout 
finished with a cooling-down period 
of 30 s.
90”: After each exercise bout, a rest 
period of 90 s was provided.
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RESULTS
Completion exercise protocol
Two healthy subjects, 20 patients with CFS and 4 patients 
with CLBP were unable to complete the exercise test. The 
total exercise duration (rest periods not included) is shown 
in Table I. 
Group characteristics
Mean and SD for age, pain intensity, quality of life, NO serum 
concentrations, and PPTs prior to and following the ergometer 
bicycle test are shown in Table II. The 3 groups were com-
parable regarding age (p = 0.843), body length (p = 0.130), 
weight (p = 0.152), and gender distribution (p = 0.116). Patients 
with CFS showed lower PPTs, both prior to and following 
exercise, compared with healthy controls and patients with 
CLBP  (p varying between < 0.001 and 0.023). No significant 
differences were found between the control subjects and pa-
tients with CLBP for any of the PPTs. Following exercise, NO 
concentrations were higher in patients with CLBP compared 
with patients with CFS (p = 0.044), but when accounting for 
BMI the difference was, however, no longer statistically 
significant. 
Changes in nitric oxide. As shown in Fig. 2, NO concentrations 
were considerably higher at baseline and increased in response 
to exercise in the CLBP-group, while they were initially 
lower and only marginal changes were seen in the CFS and 
healthy groups after exercise. However, the differences were 
not statistically significant (p = 0.207; and after accounting 
for BMI p = 0.267).
Changes in mean pressure pain thresholds. The mean PPT 
increased following exercise in healthy subjects and in pa-
tients with CLBP, and decreased in patients with CFS (Fig. 
3). These changes were statistically significant (p = 0.001) for 
all 3 groups. When comparing the patients with CFS with the 
2 other groups, they differed significantly from patients with 
CLBP (p = 0.002) and from healthy controls (p = 0.009).
Correlations between nitric oxide and mean pressure pain 
thresholds. No significant correlations between NO and PPTs 
were found (Table III). 
DISCUSSION
While many patients with low back pain recover after a few 
weeks, some patients develop CLBP with recurrent episodes 
of pain (35). We have found previously that patients with CFS 
often experience chronic widespread pain, with typical exac-
erbations of pain following exercise (36). Central mechanisms 
may be responsible for the deregulated anti-nociception. Ad-
dressing patients with CFS, the results of the present study are 
consistent with our initial hypothesis. The decreases in PPTs 
that we found following exercise suggest abnormal central 
Table I. Number and percentage of patients completing the exercise protocol for each of the 6 respective bouts
1 bout (190’’)
n (%)
2 bouts (415’’)
n (%)
3 bouts (690’’)
n (%)
4 bouts (1000’’) 
n (%)
5 bouts (1348’’)
n (%)
6 bouts (1741’’)
n (%)
Healthy (n = 31) 2 (7) 29 (93)
CFS (n = 26) 1 (4) 2 (8) 10 (38) 7 (27) 6 (23)
CLBP (n = 21) 1 (5) 3 (14) 17 (81)
(190’’) etc.: time (s) spent on the bicycle ergometer for each respective bout.
CFS: chronic fatigue syndrome; CLBP: chronic low back pain.
Table II. Demographic data, outcome measures, nitric oxide (NO) and 
pressure pain thresholds for 8 bilateral sites (PPTs; absolute and mean, 
right and left sides) before and after exercise.
Demographic data
CFS 
(n = 26)
21♀ 5♂
Mean (SD)
CLBP 
(n = 21)
11♀ 10♂
Mean (SD)
Healthy 
(n = 31)
21♀ 10♂
Mean (SD)
Age 41.52 (11.38) 41.55 (12.40) 39.88 (12.63)
Length 168.54 (8.11) 173.29 (9.62) 170.06 (6.61)
Weight 66.69 (13.80) 73.24 (11.13) 67.65 (11.33)
Outcome measures
Pain VAS 5.11 (2.31) 3.63 (2.50) 0.20 (0.44)
SF-36 300.81 
(122.50)
540.74 (129.60) 473.72 
(337.49)
ODQ – 18.57 (15.09) –
BDI 16.46 (8.77) 5.59 (4.84) 1.68 (4.339)
Measurements before exercise (NO and PPTs)
NO 8.3 (6.45) 13.36 (11.62) 9.38 (5.14)
Arm L 3.21 (2.44) 7.08 (4.38) 5.70 (3.34)
Arm R 2.95 (2.06) 6.72 (4.48) 5.64 (3.66)
Hand L 4.61 (3.18) 9.77 (3.90) 8.23 (3.06)
Hand R 4.78 (3.46) 9.35 (3.78) 8.02 (2.65)
Back L 5.12 (3.81) 8.91 (3.05) 7.77 (3.04)
Back R 4.44 (2.66) 8.43 (2.85) 7.68 (2.92)
Calf L 3.93 (2.67) 7.20 (3.16) 6.96 (3.15)
Calf R 3.75 (2.53) 7.37 (3.12) 6.88 (3.12)
Mean 4.10 (2.59) 8.10 (3.02) 7.11 (2.74)
Measurements after exercise (NO and PPTs)
NO 8.38 (6.92) 14.25 (11.94) 8.88 (5.04)
Arm L 2.51 (2.27) 7.46 (4.38) 6.10 (3.68)
Arm R 2.38 (2.23) 7.16 (4.48) 5.35 (2.93)
Hand L 3.77 (3.63) 8.47 (4.17) 7.67 (3.69)
Hand R 3.77 (3.09) 8.35 (4.35) 7.25 (3.62)
Back L 4.24 (2.46) 9.98 (3.85) 9.23 (4.28)
Back R 4.14 (3.27) 8.88 (3.45) 8.62 (3.70)
Calf L 3.59 (2.35) 8.08 (3.52) 7.84 (3.18)
Calf R 3.55 (2.40) 7.89 (3.80) 8.10 (3.26)
Mean 3.51 (2.48) 8.28 (3.49) 7.56 (3.17)
Different parts of the body represent the locations where pressure pain 
thresholds (PPT) were assessed, the values are expressed in kg/cm3. 
CFS: patients with chronic fatigue syndrome; CLBP: patients with chronic 
low back pain; SF-36: Short-Form Health Survey 36; VAS: visual analogue 
scale (cm); ODQ: Oswestry Disability Index; NO: nitric oxide (µM/l); L: 
left; R: right; –: questionnaire not completed; BDI: body density index.
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pain processing in CFS, but not in CLBP. Serum NO appears 
to be unrelated to PPTs. 
Group characteristics at baseline
The overall reduced PPTs in patients with CFS, compared 
with healthy subjects and patients with CLBP suggest gen-
eralized hyperalgesia and indicate abnormal pain processing. 
It is somewhat surprising that no hyperalgesia was found in 
patients with CLBP, while several other studies have found 
lower PPTs in patients with CLBP compared with healthy 
subjects, at locations related to the lower back (6, 7), and also 
for sites unrelated to the back (7). Our patients with CLBP 
were only mildly to moderately disabled, as suggested by the 
lower scores on the Oswestry Disability Questionnaire and the 
high scores on the SF-36. This may suggest that hyperalgesia 
is present only in the severely disabled patients with CLBP 
rather than in the entire CLBP population. 
Compared with CFS and healthy subjects, serum NO levels 
were significantly higher in the CLBP-group. After account-
ing for BMI, the difference was, however, no longer present. 
The high NO levels in patients with CLBP may indicate an 
inflammatory or degenerative process, and are in line with 
earlier reports on elevated NO production in low back pain 
(37). The observations of similar NO levels in patients with 
CFS and healthy controls is surprising, since previous studies 
have reported elevated NO levels in patients with CFS (17). 
However, Kurup & Kurup (17), analysed plasma rather than 
serum NO levels. 
Changes in nitric oxide after exercise
The NO-response to submaximal exercise did not differ be-
tween groups, even though NO levels increased in patients 
with CLBP and remained more or less stable in patients with 
CFS and healthy subjects. It is known that exercise triggers 
NO release (19), but no changes were observed in the healthy 
controls and patients with CFS. NO is a very volatile molecule 
compliant with many external factors. Furthermore, the proce-
Fig. 2. Changes in nitric oxide (μM/l) following exercise.
Control subjects.
Patients with chronic low back pain.
Patients with chronic fatigue syndrome. 
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Fig. 3. Changes in pressure pain thresholds (PPT; kg/cm3) following 
exercise.
Control subjects.
Patients with chronic low back pain. 
Patients with chronic fatigue syndrome. 
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Table III. Correlations between serum nitric oxide (NO) and mean pressure pain thresholds (PPTs) before and after exercise
 
Mean PPT before exercise Mean PPT after exercise Difference PPT
CFS  
(n = 26)
CLBP  
(n = 21)
CON  
(n = 31)
CFS  
(n = 26)
CLBP  
(n = 21)
CON  
(n = 31)
CFS  
(n = 26)
CLBP  
(n = 21)
CON  
(n = 31)
NO before R
p-value
0.101 
0.624
–0.278
0.223
–0.068
0.716
–0.035
0.865
–0.388
0.082
–0.133
0.476
0.244
0.230
0.363
0.106
0.174
0.349
NO after R
p-value
0.101
0.624
–0.380
0.089
0.015
0.936
–0.065
0.751
–0.432
0.050
–0.044
0.813
0.297
0.141
0.253
0.269
0.134
0.471
Difference NO R
p-value
–0.028
0.894
0.285
0.210
–0.009
0.961
0.125
0.541
0.141
0.542
–0.122
0.512
–0.269
0.185
0.260
0.256
0.269
0.144
R: Pearson’s correlation coefficient; p-value: significance level; CFS: chronic fatigue syndrome; CLBP: chronic low back pain; CON: control.
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dure of NO analysis is based on the analysis of the breakdown 
products nitrite and nitrate. The procedure may be insufficient 
to reveal acute changes in NO concentrations. 
Changes in mean pressure pain thresholds after exercise
The decrease in mean PPT in response to submaximal aerobic 
exercise in patients with CFS is an important finding. Our results 
extend the preliminary findings, provided by Whiteside et al., 
that exercise lowers PPTs in CFS (9). Our data also indicate that 
patients with CLBP and healthy subjects reacted “normally” to 
exercise: the PPTs increased, while they decreased in patients 
with CFS. This finding suggests a pathophysiological reaction 
to exercise. In normal circumstances, pain thresholds increase 
during and following exercise. This is due to the release of 
endogen opioids and growth factors (10) and other strong pain 
inhibitory mechanisms (“descending inhibition”) orchestrated 
by the central nervous system (11). Our data suggest a lack of 
descending inhibition during submaximal aerobic exercise in 
patients with CFS with chronic widespread pain. 
Exercise is frequently encountered as a central component 
of the treatment of chronic musculoskeletal pain. Because 
patients’ tolerance to exercise is a determining factor in treat-
ment compliance, it is important to know how chronic pain 
patients react to physical efforts. Patients with CFS are known 
to tolerate physical efforts badly, with a worsening of their 
symptoms up to 48 h after an acute bout of exercise and to 
have a very slow recovery (12, 38). Pain complaints worsen 
following exercise in patients with CFS, possibly as the result 
of decreased pain thresholds in response to exercise. Also the 
findings of Jammes et al. (39) may explain the muscle pain 
following exercise reported by patients with CFS. It has been 
reported that patients with CFS respond to incremental exercise 
with lengthened and accentuated oxidative stress, together with 
marked alterations of the muscle membrane excitability (38). 
Furthermore, evidence for immune deregulation in patients 
with CFS following (sub)maximal exercise (14), causing post-
exertional malaise, which can include pain, has been published. 
Together, these findings may explain the symptom exacerbation 
and decreased PPTs following exercise.
In our healthy subjects and in the patients with CLBP, PPTs 
increased in response to submaximal aerobic exercise. These 
results are consistent with the pilot study by Hoffman et al. 
(40), which to our knowledge is the only study analysing pain 
response in relation to exercise in patients with CLBP. Thus, 
pain physiology during exercise seems to be normal in mildly 
disabled patients with CLBP. 
Correlation between nitric oxide and mean pressure pain 
thresholds
NO is able to reduce central pain inhibition (18), and may in-
duce peripheral and central sensitization by reducing receptor 
thresholds (37). However, we found no correlations between 
NO and PPTs. Thus, our study supports the hypothesis that 
central nociceptive mechanisms are deregulated in CFS, but 
NO does not seem to play a role and NO also appeared to be 
unrelated to pain in the patients with CLBP.
Study limitations. Our results should be interpreted in light 
of the study limitations. It was not easy to standardize the 
exercise protocol for the 3 groups, given the great inter-
individual differences in exercise capacity. It is probable that 
not all participants ended the exercise tests at a similar point 
of exhaustion. Therefore, the exercise time was entered as 
covariate in the analysis. Further research should use more 
standardized submaximal exercise protocols and also address 
a dose-response relationship to determine which exercise 
stimuli cause which response in order to steer rehabilitation 
programmes. Also, the pathophysiology behind the impaired 
pain inhibition deserves further attention. Although NO quan-
tification is often sensitive to bias, the present results do not 
point to a specific role for NO in chronic pain experienced by 
patients with CFS or CLBP. 
Furthermore, the issue of selection bias should be addressed. 
Patients with CFS were asked whether they were able to cycle 
prior to inclusion into the study. This may lead to recruitment 
of less severely disabled patients with CFS. The recruitment 
of healthy controls and patients with CLBP via pamphlets and 
physical therapists may also imply selection bias. Pamphlets 
were distributed in the university, university hospital and in 
physical therapy practices, and consequently reached a select 
population. The same applies to relatives and acquaintances of 
the researchers. Finally, participants reported having followed 
instructions and ceased medication use 24 h prior to study par-
ticipation, but we cannot be sure that this was in fact the case.
In conclusion, patients with CFS manifest generalized 
hyperalgesia. The results of the present investigation might 
suggest the presence of abnormal central pain processing 
during submaximal aerobic exercise. Mean PPTs in patients 
with CFS decreased following sub-maximal bicycle ergometer 
exercise, while increased PPTs were seen in the CLBP and the 
healthy groups. Because of the great inter-individual differ-
ences in exercise capacity, more research may be warranted 
to address a dose-response relation. NO concentrations were 
higher among patients with CLBP, and increased following 
submaximal aerobic exercise, while they were considerably 
lower and changed only marginally in patients with CFS and 
healthy controls. NO appears to be unrelated to widespread 
pain and exacerbation of pain following exercise in the CFS 
and CLBP groups. 
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